Citadel Advisors

Citadel Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Citadel Advisors’s Portfolio SPRY Stock Details SPRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$418K	Buy	52,000 +35,200	+210%	+$337K	﹤0.01%	9735
2025 Q4	$196K	Buy	16,800 +2,000	+14%	+$19.4K	﹤0.01%	11065
2025 Q3	$149K	Sell	14,800 -3,300	-18%	-$47.4K	﹤0.01%	11537
2025 Q2	$316K	Sell	18,100 -10,800	-37%	-$156K	﹤0.01%	9697
2025 Q1	$364K	Buy	28,900 +17,200	+147%	+$207K	﹤0.01%	9159
2024 Q4	$123K	Buy	11,700 +9,100	+350%	+$127K	﹤0.01%	11143
2024 Q3	$37.7K	Sell	2,600 -17,500	-87%	-$208K	﹤0.01%	12208
2024 Q2	$171K	Sell	20,100 -5,100	-20%	-$45.3K	﹤0.01%	10155
2024 Q1	$258K	Sell	25,200 -6,800	-21%	-$50.7K	﹤0.01%	9797
2023 Q4	$175K	Sell	32,000 -17,100	-35%	-$74.9K	﹤0.01%	10140
2023 Q3	$186K	Buy	49,100 +9,100	+23%	+$59.7K	﹤0.01%	10039
2023 Q2	$268K	Buy	40,000 +2,400	+6%	+$16K	﹤0.01%	9286
2023 Q1	$245K	Sell	37,600 -2,000	-5%	-$15.4K	﹤0.01%	9800
2022 Q4	$338K	Buy	39,600 +27,400	+225%	+$178K	﹤0.01%	9062
2022 Q3	$64K	Sell	12,200 -49,100	-80%	-$242K	﹤0.01%	11451
2022 Q2	$260K	Buy	+61,300	New	+$214K	﹤0.01%	10137

Other funds holding SPRY

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return